Hamna Asim

iShares Core U.S. REIT ETF (NYSE:USRT) aims to mirror the performance of the FTSE Nareit Equity REITs Index. This fund caters to investors seeking both income and growth, offering broad exposure to different sectors of the US real estate market. As of March 28, 2024, the fund's net assets amounted to $2.3 billion and its net expense ratio came in at 0.08%. The ETF's portfolio consists of 131 stocks.

In this article, we discuss 10 best real estate ETFs to buy. If you want to skip our discussion on the real estate market, head over to 5 Best Real Estate ETFs To Buy Now. Despite economic challenges worldwide, real estate industry leaders surveyed by PwC are hopeful for a potential uptick in investment activity, […]

En este artículo: AMZN In this article, we discuss 10 best retail ETFs to buy. If you want to skip our discussion on the retail industry, head over to

Consumer Discretionary Select Sector SPDR Fund (NYSE:XLY) aims to match the price and yield performance of the Consumer Discretionary Select Sector Index. This index represents the consumer discretionary sector of the S&P 500 Index. The fund provides targeted exposure to companies across specialty retail, broadline retail, hotels, restaurants and leisure, textiles, apparel and luxury goods, household durables, automobiles, automobile components, distributors, leisure products, and diversified consumer services. Consumer Discretionary Select Sector SPDR Fund (NYSE:XLY) ranks 5th on our list of the best retail ETFs. The fund was established on December 16, 1998. As of April 1, 2024, the ETF has a gross expense ratio of 0.09%, and a portfolio of 53 stocks. The assets under management came in at $20 billion.

The new era in biotech is defined by the convergence of biology, data, and artificial intelligence.

Virtus LifeSci Biotech Products ETF (NYSE:BBP) aims to mirror the performance of the LifeSci Biotechnology Products Index, which monitors biotechnology firms with at least one FDA-approved drug therapy, before accounting for fees and expenses. As of April 1, 2024, the fund owns $19.7 million in net assets, with an expense ratio of 0.79%. It is one of the best biotech ETFs to monitor.

En este artículo: MSFT In this article, we discuss 10 best low volatility ETFs to buy. If you want to skip our discussion on low volatility investments, head over to

The Vanguard Russell 3000 Index Fund ETF (NASDAQ:VTHR) seeks to mirror the performance of the Russell 3000 Index, which represents 98% of the entire US market. The ETF was launched on September 20, 2010. As of March 31, 2024, it has net assets amounting to $3.5 billion, with a portfolio of 2,917 stocks. The expense ratio stands at 0.10% as of December 22, 2023, and it is one of the best low cost ETFs.

In this article, we discuss 12 best large-cap growth ETFs. If you want to skip our discussion on growth investing, head over to 5 Best Large-Cap Growth ETFs. Large-cap growth funds focus on investing in big companies, those in the top 70% in terms of market value. Growth funds constitute companies expected to grow their […]

Vanguard Growth Index Fund ETF Shares (NYSE:VUG) aims to replicate the CRSP US Large Cap Growth Index's performance, offering a simple way to mirror the performance of numerous major American growth stocks. It utilizes a passively managed, full-replication strategy. Vanguard Growth Index Fund ETF Shares (NYSE:VUG) was founded on January 26, 2004. The ETF's expense ratio has remained 0.04% since April 28, 2023. As of March 31, 2024, Vanguard Growth Index Fund ETF Shares (NYSE:VUG) holds 199 stocks in its portfolio, and the fund features net assets of $226.5 billion. VUG ranks 5th on our list of the best large-cap growth ETFs.